Cheviot Value Management, LLC Abbott Laboratories Transaction History

Cheviot Value Management, LLC

$487 Million
Q4 2024

A detailed history of Cheviot Value Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cheviot Value Management, LLC holds 14,410 shares of ABT stock, worth $2.02 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

14,410

Previous 14,600 1.3%

Holding current value

$2.02 Million

Previous $1.66 Million 2.1%

% of portfolio

0.33%

Previous 0.34%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $21,266 - $22,684	-190 Reduced 1.3%	14,410 $1.63 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $50,835 - $60,010	-508 Reduced 3.36%	14,600 $1.66 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $9,569 - $10,681	-95 Reduced 0.62%	15,108 $1.57 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $78,306 - $86,486	-715 Reduced 4.49%	15,203 $1.73 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $45,095 - $55,200	-500 Reduced 3.05%	15,918 $1.75 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $143,103 - $171,700	-1,498 Reduced 8.36%	16,418 $1.59 Million
Q2 2023 Nov 07, 2023	SELL	$100.78 - $112.29 $27,512 - $30,655	-273 Reduced 1.5%	17,916 $1.95 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $24,699 - $29,072	-255 Reduced 1.38%	18,189 $1.84 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.19 Million - $1.4 Million	-12,532 Reduced 40.46%	18,444 $2.03 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $91,341 - $105,756	-944 Reduced 2.96%	30,976 $3 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $53,892 - $65,139	-528 Reduced 1.63%	31,920 $3.47 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $327,351 - $399,183	-2,871 Reduced 8.13%	32,448 $3.84 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $102,012 - $124,909	-883 Reduced 2.44%	35,319 $4.97 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $111,293 - $123,123	-954 Reduced 2.57%	36,202 $4.28 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $296,529 - $349,057	-2,803 Reduced 7.01%	37,156 $4.31 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $44,189 - $52,061	-406 Reduced 1.01%	39,959 $4.79 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $9,660 - $10,526	-92 Reduced 0.23%	40,365 $4.42 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $15,670 - $19,030	-171 Reduced 0.42%	40,457 $4.4 Million
Q2 2020 Aug 17, 2020	SELL	$76.57 - $98.0 $53,369 - $68,306	-697 Reduced 1.69%	40,628 $3.72 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $78,525 - $114,825	-1,250 Reduced 2.94%	41,325 $3.26 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $91,385 - $101,733	-1,164 Reduced 2.66%	42,575 $3.7 Million
Q3 2019 Nov 15, 2019	SELL	$81.84 - $88.74 $18,741 - $20,321	-229 Reduced 0.52%	43,739 $3.66 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $9,620 - $11,220	-132 Reduced 0.3%	43,968 $3.7 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $75,689 - $91,508	-1,143 Reduced 2.53%	44,100 $3.53 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $321,244 - $363,923	-4,900 Reduced 9.77%	45,243 $3.27 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $125,511 - $151,415	-2,064 Reduced 3.95%	50,143 $3.68 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $378,004 - $417,203	-6,566 Reduced 11.17%	52,207 $3.18 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $87,724 - $99,183	-1,559 Reduced 2.58%	58,773 $3.52 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $24,639 - $26,378	-459 Reduced 0.76%	60,332 $3.44 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $19,512 - $21,777	406 Added 0.67%	60,791 $3.24 Million
Q2 2017 Aug 11, 2017	BUY	N/A	60,385	60,385 $2.94 Million

Others Institutions Holding ABT

# of Institutions

3,371

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $246B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.

Account

Cheviot Value Management, LLC Abbott Laboratories Transaction History